Case Control Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Oct 21, 2015; 21(39): 11152-11159
Published online Oct 21, 2015. doi: 10.3748/wjg.v21.i39.11152
Table 3 Correlations of serum 25(OH)D3 and 24,25(OH)2D3 levels, and the 25(OH)D3/24, 25(OH)2D3 ratio, with clinical parameters
25(OH)D3 (ng/mL)
24,25(OH)2D3 (ng/mL)
25(OH)D3/24,25(OH)2D3
r valueP valuer valueP valuer valueP value
Age (yr)-0.0340.711-0.1320.150-0.1340.145
ALT (U/L)-0.0620.5020.1750.055-0.2300.012
AST (U/L)0.0360.6930.1690.066-0.1490.104
TBIL (μmol/L)-0.1240.1770.0880.337-0.1760.054
DBIL (μmol/L)-0.1650.0720.1090.065-0.2820.002
TP (g/L)-0.1260.1700.1360.138-0.1850.043
ALB (g/L)0.0270.7700.1200.193-0.1120.223
GGT (U/L)-0.1430.1190.1040.260-0.2110.021
CHE (U/L)-0.0150.871-0.0580.526-0.0110.906
Ca (mmol/L)0.0270.7680.2000.028-0.1580.084
P (mmol/L)0.0880.337-0.1300.1580.2660.003
HB (g/L)-0.0400.6650.1330.149-0.1950.033
PTA (%)0.1090.237-0.1340.1450.2310.011
Liver fibrosis-0.0520.5740.0230.807-0.0720.435
Liver inflammation-0.1040.258-0.1290.1600.0690.451
Viral load( IU/mL)0.0740.4640.1730.086-0.1310.196
25(OH)D3 (ng/mL)--0.410< 0.001--
24,25(OH)2D3 (ng/mL)0.410< 0.001----